Koers Helius Medical Technologies Inc Other OTC
Aandelen
US42328V1089
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 703K 648K | Omzet 2025 * | 4,17 mln. 3,84 mln. | Marktkapitalisatie | 4,09 mln. 3,77 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -10 mln. -9,21 mln. | Nettowinst (verlies) 2025 * | -13 mln. -11,98 mln. | EV/omzet 2024 * | 5,82 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,98 x |
K/w-verhouding 2024 * |
-0,28
x | K/w-verhouding 2025 * |
-0,57
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,7% |
Recentste transcriptie over Helius Medical Technologies Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04-08-17 |
Director of Finance/CFO | 63 | 09-06-20 | |
Chief Tech/Sci/R&D Officer | 57 | 08-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward Straw
BRD | Director/Board Member | 85 | 18-11-14 |
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04-08-17 |
Blane Walter
CHM | Chairman | 53 | 29-12-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,74% | 228 mld. | |
+14,13% | 196 mld. | |
+17,38% | 141 mld. | |
+28,89% | 110 mld. | |
+1,06% | 65,88 mld. | |
+17,79% | 54,3 mld. | |
+7,63% | 52,39 mld. | |
+11,10% | 45,22 mld. | |
+4,78% | 37,12 mld. |